Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by ADNAN IKHTIAR
Three‑way Philadelphia Translocation T(9;10;22)(q34;p11.2;q11.2) as a Secondary Abnormality in an Imatinib Mesylate‑resistant Chronic Myeloid Leukemia Patient
Oncology Letters
Cancer Research
Oncology
Related publications
Complex Three-Way Philadelphia Translocation T(6;9;22) (P23;q34;q11.2) Along With Unusual T(1;4): A Chronic Myeloid Leukemia Case Report
International Journal of Molecular and Immuno Oncology
A New T(9;11;20;22)(q34;p11.2;q11.21;q11) in a Philadelphia-Positive Chronic Myeloid Leukemia Case
Oncology Letters
Cancer Research
Oncology
T(3;4)(p21;q34) as a Sole Anomaly in Acute Myeloid Leukemia Patient
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Development of Multiple Myeloma in a Patient With Chronic Myeloid Leukemia After Treatment With Imatinib Mesylate
Oncologist
Cancer Research
Medicine
Oncology
Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia
Haematologica
Hematology
Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients
Hematology Reports
Hematology
Chromosomal Abnormalities in Philadelphia Chromosome Negative Metaphases Appearing During Imatinib Mesylate Therapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Secondary Myelodysplastic Syndrome in a Patient With Philadelphia-Positive Acute Lymphoblastic Leukemia After Achieving a Major Molecular Response With hyperCVAD Plus Imatinib Mesylate
Leukemia Research
Cancer Research
Oncology
Hematology
